EMS
DEAD

Serial Number

85354510

Owner

EMS S.A.

Attorney

LEWIS F. GOULD, J R.

Filing Date

Jun 23, 2011

Add to watchlist:

No watchlists yet
View on USPTO

EMS Trademark

Serial Number: 85354510

EMS is a trademark filed by EMS S.A. on June 23, 2011. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

EMS S.A. (19 trademarks)

Sao Bernando do Campo
Sao Paulo Centro,CE , BR

Entity Type: 03

Trademark Details

Filing Date

June 23, 2011

Registration Date

Not Registered

Published for Opposition

June 18, 2013

Goods & Services

Medical, pharmaceutical, and therapeutic preparations for use with humans, namely, Statins (HMG-COA reductase Inhibitors), Oral broad spectrum penicillins, Acid pump inhibitors, Non-narcotic analgesics, anti-pyretics, multivitamins with minerals, medications for erectile dysfunction, plain Angiotensin-II antagonist, plain ACE inhibitors, non-steroidal plain Anti-Rheumatics, Expectorants, Oral fluoroquinolones, Systemic antihistamines, SSRI Antidepressants, Antiobesity preparations, Macrolides, Oral cephalosporins, Bisphosphonates for osteoporosis and related disorders, plain Beta-blocking agents, tranquilizers, plain Calcium antagonists, topical nasal preparations, Cyclo-Oxygenase inhibitor platelet aggregation inhibitors, Anti-epileptics, Antidiarrheal micro-organisms, Appetite stimulants, Agents for systemic fungal infections, ADP (Adenosine Diphosphate) receptor antagonist platelet inhibitors, Geriatric monophasic preparations with estrogen, Plain antiflatulents and carminatives, plain oral corticosteroids, iron supplements, Antispasmodic/analgesic combinations, plain Thiazides and analogues, Plain vitamin C and vitamin C salts, centrally acting Muscle relaxants, Simple biguanide, Plain vitamin B complex, Atypical antipsychotics, antihelmintics, antireumaticos and topical analgesics, Sulfonylurea antidiabetics, systematic hormonal contraceptives, H2 antagonists, Gynecological antifungals, Combinations with anti-hypertensives and/or diuretics, topical musculo-skeletal preparations, plain Potassium-sparing agents, Angiotensin-II antagonist combinations with antihypertensives (C2) and/or diuretics, plain BPH 5-alpha testosterone reductase inhibitors (5-ARI), Plain topical corticosteroids, Systemic corticosteroid combinations, Antidepressants, Throat preparations, Herpes antivirals, Systemic nasal preparations, wound healing agents with antibacterials and antifungals, dermatological preparations, Gastroprokinetics, Injectable cephalosporins, Fibrates, Topical dermatological antifungals, plain BPH alpha-adrenergic antagonists, plain Antihypertensives, urinary antiseptics, topical antibacterials, Iron combination supplements, corticosteroid combinations, Topical antivirals, Topical trichomonacides with antifungals, Vitamin C combinations, Plain antacids, laxatives, Intestinal anti-inflammatory agents, Cerebral and peripheral vasotherapeutics, Stomatologicals, Enemas, Oral anti-acne preparations, Androgens. Topical Scalp antifungals, ACE inhibitor combinations with antihypertensives (C2) and / or diuretics (C3), SNRI Antidepressants with antibacterials, Antimigraine triptans, Tetracyclines and combinations, plain Non-barbiturates, Alpha-glucosidase inhibitors, Mouth Antifungals, Calcium antagonists with cerebral activity, Potassium-sparing agents with thiazides and / or analogue combinations, Cold preparations without anti-infectives, Antiulcerants, Synthetic antifibrinolytics, Ocular decongestants, Sympathomimetics, Herbal hypnotics/sedatives, Nasal decongestants, systematic B2-stimulants, gynecological antibacterials, choleretics and cholekinetics, plain anticholinergics inhalants, Otic corticosteroid / anti-infective combinations, Vitamin D, Systemic trichomonacides, plain Injectable corticosteroids, Triphasic preparations, Antispasmodics, local topical Anesthetics, Gonadotrophins and ovulation stimulants, gynecological antiseptics, Ophthalmological corticosteroid and anti-infective combinations, Calcium supplements, anti-migraine preparations, Progestogens, amoebicides, Ophthalmological anti-infectives, anti-anemic preparations, folic and folic acids, Plain antispasmodics and anticholinergics, urinary antibacterials, Trimethoprim and similar formulations, simple glitazones, Antacids with antiflatulents or carminatives, systemic non-steroidal respiratory anti-inflammatories, topical anti-acne preparations, topical products used in viral infections, Glina simple, Gynecological antispasmodics, plain Vitamin E, Intestinal anti-infective antidiarrheal preparations, multivitamins without minerals; Anti-smoking products, namely, smoking cessation preparations; Immunosuppressants, Antiseptics and disinfectants for sanitary purposes; Bulk producers, namely, laxatives; Oral electrolyte replacers and tonics, Ophthalmic non-steroidal anti-inflammatories, Anti-pruritics and topical antihistamines, anesthetics, Anti-Alzheimer preparations, cholinesterase inhibitors, Vitamin B1combinations with vitamin B6 and/or vitamin B12, Urinary incontinence preparations, Plain antitussives, Nasal anti-allergic agents, Digestives for pharmaceutical purposes; enzymes for pharmaceutical purposes; Prenatal urological preparations, Conventional antipsychotics, Platelet CAMP enhancing platelet aggregation inhibitors, Serotonin antagonist antiemetics / antinauseants, Anti-parkinson drugs, estrogens, oral Progestogen-only preparations, Injectable broad spectrum penicillins, Neurotonics, Plain medium narrow penicillins, Intestinal adsorbent antidiarrheals, Cough / cold preparations with anti-infectives, Antitussives in combinations, Otic anti-infectives, estrogen with progestogen combinations. Ectoparasiticides and scabicides, plain loop diuretics, Cardiac dopaminergic agents, antiemetics and antinauseants, Magnesium supplements, vitamin B1 combinations, Plain cardiac glycosides, all of the aforementioned goods excluding dental pharmaceutical goods

Personal hygiene and cosmetic preparations, namely, shampoo; toilet soap; hair conditioner; deodorant; bath oil; skin cleansing lotion; moisturizing cream; sun care, sun block and sun tan lotion; body deodorant and perfumes; skin emollients; all excluding shaving products

Commercialization services in the field of import and export of products, namely, assistance in business management and product commercialization, within the framework of a franchise contract with respect to pharmaceutical products, alopathic, homeopathic, veterinary, food, diet, hygiene, dressing, cosmetics, perfumes, sanitizing, phytosanitary, and domisanitary products, pharmaceutical inputs, drugs and related products, synthesis of antibiotic, fine chemistry and industrial chemistry, herbs for infusion, plant oils, powders for soft drinks; import and export agencies in the fields of pharmaceutical products, alopathic, homeopathic, veterinary, food, diet, hygiene, dressing, cosmetics, perfumes, sanitizing, phytosanitary, and domisanitary products, pharmaceutical inputs, drugs and related products, synthesis of antibiotic, fine chemistry and industrial chemistry, herbs for infusion, plant oils, powders for soft drinks

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 14, 2015 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 14, 2015 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 24, 2015 EXRA
SOU EXTENSION 3 GRANTED
Feb 23, 2015 EX3G
SOU EXTENSION 3 FILED
Feb 9, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 9, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2014 EXRA
SOU EXTENSION 2 GRANTED
Aug 25, 2014 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 25, 2014 AITU
SOU EXTENSION 2 FILED
Aug 4, 2014 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 4, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 24, 2014 EXRA
SOU EXTENSION 1 GRANTED
Jan 22, 2014 EX1G
SOU EXTENSION 1 FILED
Jan 22, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 22, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 13, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 10, 2013 PREV
ASSIGNED TO LIE
May 9, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 30, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 30, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 30, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 30, 2013 CNEA
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Nov 20, 2012 UNTD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 20, 2012 AITU
EXAMINER'S AMENDMENT ENTERED
Nov 16, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 16, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 16, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 16, 2012 CNEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 14, 2012 PARI
EMAIL RECEIVED
Nov 12, 2012 EMRV
EXAMINER'S AMENDMENT ENTERED
Nov 12, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 12, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 12, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 12, 2012 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 12, 2012 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 8, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 8, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 8, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 8, 2012 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2012 TROA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 23, 2012 AITU
TEAS REQUEST TO DIVIDE RECEIVED
Oct 23, 2012 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 23, 2012 GNRN
NON-FINAL ACTION E-MAILED
Apr 23, 2012 GNRT
NON-FINAL ACTION WRITTEN
Apr 23, 2012 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2012 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 5, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 5, 2011 GNRN
NON-FINAL ACTION E-MAILED
Oct 5, 2011 GNRT
NON-FINAL ACTION WRITTEN
Oct 5, 2011 CNRT
ASSIGNED TO EXAMINER
Oct 5, 2011 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Jun 30, 2011 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 29, 2011 NWOS
NEW APPLICATION ENTERED
Jun 27, 2011 NWAP